Novo and Lilly’s campaigns are not limited to advertisements alone, and both companies are trying to raise awareness around obesity through research studies and conferences.

“While (Eli Lilly’s ) injectables have got approval ... sales of these drugs will happen only by mid-2025," informs Mumbai-based Dr Rajiv Kovil, head of diabetology at Zandra Healthcare.

India's largest drugmaker by revenue Sun Pharmaceutical is aiming to launch its experimental anti-obesity and type 2 diabetes drug in the next four to five years, Managing Director Dilip Shanghvi said ...

“We are also keenly looking at it," Majumdar, who leads the company’s specialty division out of Mumbai, said ... Innovator Eli Lilly, whose weight loss drug Tirzepatide is sold under brand ...

And they represent every vertical and horizontal one can think of—from the large financial companies, with their massive centres, to drug companies such as Novo Nordisk and Eli Lilly—which has ...

Eli Lilly and Co. is in negotiations with several states and plans to announce the locations of four new manufacturing plants later this year.

Eli Lilly plans to launch its blockbuster diabetes and weight-loss drug in major emerging markets like India, Brazil and ...

Like many pharma stocks, Eli Lilly (NYSE: LLY) offers investors a bit of safety -- and it's an element you can count on during any economic environment. This is because patients need their ...

Feb. 26 (UPI) --Eli Lilly announced plans for four new pharmaceutical manufacturing sites to produce domestic medicine production in the United States and make the nation the world's leader in ...

Eli Lilly is expanding the supply and cutting the costs of its weight-loss drug Zepbound, broadening access to more patients without insurance. The company launched 7.5 mg and 10 mg vials of ...